Wednesday, May 23, 2012

Avoiding Prostate Cancer Screening Might Be Costly

E. David Crawford, MD, head of the section of urologic oncology at the University of Colorado Health Sciences Center in Denver, and colleagues presented an analysis of the recommendations in a late-breaking oral session here at the American Urological Association 2012 Annual Scientific Meeting.
This week, the USPSTF gave prostate cancer screening a grade of D (not recommended; harm outweighs benefits or no net benefit). However, the analysis by Dr. Crawford and colleagues suggests that avoiding prostate cancer screening might ultimately cost more in terms of treating advanced disease and missing significant numbers of cases.



Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More

Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Bluehost Review